Highly concise routes to epothilones: The total synthesis and evaluation of epothilone 490BISWAS, Kaustav; HONG LIN; NJARDARSON, Jon T et al.Journal of the American Chemical Society. 2002, Vol 124, Num 33, pp 9825-9832, issn 0002-7863Article

Radiosynthesis of 1'-[¹⁸F]fluoroethyl-β-D-lactose ([¹⁸F]-FEL) for early detection of pancreatic carcinomas with PETTURKMAN, Nashaat; PAL, Ashutosh; TONG, William P et al.Journal of labelled compounds & radiopharmaceuticals. 2011, Vol 54, Num 5-6, pp 233-238, issn 0362-4803, 6 p.Article

Radiosynthesis of 6 -([¹⁸F]fluoroacetamido ) -1 -hexanoic-anilide ([¹⁸F]FAHA) for PET imaging of histone deacetylase (HDAC)MUKHOPADHYAY, Uday; TONG, William P; GELOVANI, Juri G et al.Journal of labelled compounds & radiopharmaceuticals. 2006, Vol 49, Num 11, pp 997-1006, issn 0362-4803, 10 p.Article

An ¹⁹F magnetic resonance-based In vivo assay of solid tumor methotrexate resistance: Proof of principleSPEES, William M; GADE, Terence P. F; GUANGLI YANG et al.Clinical cancer research. 2005, Vol 11, Num 4, pp 1454-1461, issn 1078-0432, 8 p.Article

PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemiaWOLFF, Nicholas C; VEACH, Darren R; TONG, William P et al.Blood. 2005, Vol 105, Num 10, pp 3995-4003, issn 0006-4971, 9 p.Article

Therapeutic cure against human tumor xenografts in nude mice by a microtubule stabilization agent, fludelone, via parenteral or oral routeCHOU, Ting-Chao; HUAJIN DONG; XIUGUO ZHANG et al.Cancer research (Baltimore). 2005, Vol 65, Num 20, pp 9445-9454, issn 0008-5472, 10 p.Article

Complex target-oriented total synthesis in the drug discovery process: The discovery of a highly promising family of second generation epothilonesRIVKIN, Alexey; YOSHIMURA, Fumihiko; GABARDA, Ana E et al.Journal of the American Chemical Society. 2003, Vol 125, Num 10, pp 2899-2901, issn 0002-7863, 3 p.Article

A phase I trial of perillyl alcohol in patients with advanced solid tumorsAZZOLI, Christopher G; MILLER, Vincent A; NG, Kenneth K et al.Cancer chemotherapy and pharmacology. 2003, Vol 51, Num 6, pp 493-498, issn 0344-5704, 6 p.Article

The migrastatin family: Discovery of potent cell migration inhibitors by chemical synthesisGAUL, Christoph; NJARDARSON, Jon T; SHAN, Dandan et al.Journal of the American Chemical Society. 2004, Vol 126, Num 36, pp 11326-11337, issn 0002-7863, 12 p.Article

Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancerMORRIS, Michael J; TONG, William P; DIPAOLA, Robert S et al.Clinical cancer research. 2002, Vol 8, Num 3, pp 679-683, issn 1078-0432Article

Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatinLAURIE, Scott A; PFISTER, David G; KRIS, Mark G et al.Clinical cancer research. 2001, Vol 7, Num 3, pp 501-509, issn 1078-0432Article

Co-administration of probenecid, an inhibitor of a cMOAT/MRP-like plasma membrane ATPase, greatly enhanced the efficacy of a new 10-deazaaminopterin against human solid tumors in vivoSIROTNAK, F. M; WENDEL, H. Guido; BORNMANN, William G. B et al.Clinical cancer research. 2000, Vol 6, Num 9, pp 3705-3712, issn 1078-0432Article

Calvert's formula for dosing carboplatin: Overview and concerns of applicability in high-dose settingMAZUMDAR, Madhu; SMITH, Alex; TONG, William P et al.Journal of the National Cancer Institute. 2000, Vol 92, Num 17, pp 1434-1436, issn 0027-8874Article